CVS Health (CVS) delivers a year-over-year improvement in revenues, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments.
CVS Health (CVS) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $2.21 per share a year ago.
Shares in CVS Health Corp (NYSE:CVS) were under pressure pre-market after it lowered full-year forecasts due to medical costs. The impact of the news was partially offset by a second-quarter earnings print that exceeded expectations.
The healthcare giant cut its 2024 earnings outlook, citing higher medical costs in its insurance business.
Shares of CVS Health Corp. CVS, +0.92% dropped 2.3% in premarket trading Wednesday, after the drugstore chain beat second-quarter profit expectations but missed on revenue and lowered its full-year outlook, citing weakness in its health care benefits business. Net income fell to $1.77 billion, or $1.41 a share, from $1.90 billion, or $1.48 a share, in the same period a year ago.
CVS Health Corp on Wednesday cut its 2024 profit forecast, hit by increased medical costs at its health insurance unit as demand for healthcare services remained elevated.
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE: CVS ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.
Pharmacy giant CVS Health (CVS) reports second-quarter earnings ahead of the opening bell Wednesday, after its first-quarter results sent the company's stock sinking nearly 17%, its worst day of the year.
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.